Liz Rockett
Managing Director @ Kaiser Permanente Ventures
Oakland, United States
Liz Rockett is a Series B investor at Kaiser Permanente Ventures in Oakland focused on Medical and Health Care. Liz Rockett - Managing Director @ Kaiser Permanente Ventures
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Liz Rockett invests in
Stages Liz Rockett invests in
Countries Liz Rockett invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 2 (33%)
- Health Care 2 (33%)
- Therapeutics 2 (33%)
- Hospital 1 (17%)
- Software 1 (17%)
Stage
- Series B 4 (67%)
- Series C 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $75M / Series C / Jan 19, 2022 | ||
| DexCare is a provider of platform-as-a-service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform them into a highly scalable digital experience for their patients— increasing revenue from new,digital-first patients while minimizing new patient acquisition costs.DexCare was founded in 2021 and is headquartered in Seattle, WA. | $50M / Series B / Jan 13, 2022 | ||
| Everytable aims to redefine the food landscape the same way McDonald’s did fifty years ago. But this time, instead of burgers and fries, they are selling nutritious, fresh, made-from-scratch food, at fast-food prices. | $16M / Series B / Nov 17, 2020 | ||
| Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $39M / Series B / Jun 18, 2020 | ||
| Chrono Therapeutics (CHRONO) is a pharmaceutical company founded in 2004 with a vision of transforming disease and addiction management to become the market leader in programmable passive transdermal drug delivery (TDD) that offers real-time behavioral support. Chrono’s executive leadership combines years of professional experience and personalpassions for developing life-saving medical products. Steeped with years of experience in product development, science, R&D an understanding of the consumer smoking cessation market, FDA approval experience and bringing life-saving products to market, the team represents a wide-array of knowledge that combined can help address the serious epidemic of smoking. | $47.6M / Series B / Sep 08, 2016 | ||
| Big Health is a digital therapeutics company that operates a digital healthcare portal to offer fully-automated and highly personalized digital therapeutics and behavioral programs for mental health issues. Its portal offers an online personalized medicine-care and prepares a sleep improvement program in consultation with medical professionals thatenable individuals to overcome their sleep-related disorders in an efficient manner. | $12M / Series B / Jul 27, 2016 |
Co-Investors
Kaiser Permanente Ventures, the corporate venture capital arm of Kaiser Permanente, is dedicated to forming effective partnerships with innovative companies. Kaiser Permanente Ventures invests predominantly in HCIT and services, as well as diagnostics, drug delivery and therapeutic medical devices.
Kaiser Permanente Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amy Belt Raimundo
Managing Director
|
|||
Bryan Sivak
Managing Director
|
|||
Christopher Grant
Executive Vice President and Chief Operating Officer
|
|||
Jodie Ha
Associate
|
|||
|
Liz Rockett
Managing Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Liz Rockett invest in?
Liz Rockett invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B and Series C stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Liz Rockett?
Public channels for Liz Rockett include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Liz Rockett last invest?
The most recent investment recorded for Liz Rockett closed in Jan 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
